Spyre Therapeutics, Inc. (NASDAQ: SYRE) has caught the attention of investors with its promising potential upside, pegged at an impressive 225.56%. As a clinical-stage biotechnology company, Spyre is at the..
Semler Scientific, Inc. (NASDAQ: SMLR), a player in the healthcare sector specializing in medical devices, is garnering attention from investors due to its potential upside of 142.91%. With a current..
CureVac N.V. (NASDAQ: CVAC), a prominent player in the biotechnology sector, is at the forefront of mRNA-based therapeutic and vaccine development. With a current market capitalization of $1.24 billion and..
GH Research PLC (GHRS), a biotechnology firm headquartered in Dublin, Ireland, is capturing investor attention with its innovative approach to treating depression and its impressive potential upside. Specializing in the..
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) stands out in the competitive biotech sector with a compelling investment narrative. As a clinical-stage biopharmaceutical company, MindMed focuses on developing innovative products to..
AnaptysBio, Inc. (NASDAQ: ANAB) is capturing attention in the biotech investment community with its compelling potential upside of 127.84%, making it a noteworthy candidate for investors interested in high-growth opportunities..
Eton Pharmaceuticals, Inc. (ETON) stands out in the healthcare sector, particularly within the specialized realm of drug manufacturers focusing on rare diseases. With a market capitalization of $447.85 million, Eton..
Delcath Systems, Inc. (NASDAQ: DCTH), a company at the forefront of interventional oncology, is currently capturing investor attention with its promising prospects in liver cancer treatment technologies. Based in New..
Bicycle Therapeutics plc (NASDAQ: BCYC) stands out in the biotechnology sector with an impressive potential upside of 223.97%, according to analyst ratings. The company, headquartered in Cambridge, UK, is pioneering..
Castle Biosciences, Inc. (CSTL) is making waves in the healthcare sector with its innovative approach to molecular diagnostics. Specializing in dermatologic cancers and mental health conditions, this company has carved..
Enhabit, Inc. (EHAB), a key player in the U.S. healthcare sector, has garnered attention among investors with its specialization in home health and hospice services. Based out of Dallas, Texas,..
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) offers investors a compelling opportunity within the biotechnology sector, specifically targeting the niche market of hereditary angioedema (HAE) treatments. With a market capitalization of $646.9..
Definitive Healthcare Corp. (NASDAQ: DH), a key player in the health information services sector, is capturing attention with a potential upside of 19.41% as per the latest analyst ratings. While..
Akebia Therapeutics, Inc. (NASDAQ: AKBA) presents a compelling opportunity for investors with its promising pipeline in the healthcare sector. Focused on developing therapeutics for patients with kidney diseases, the company..
HealthStream, Inc. (NASDAQ: HSTM) offers investors a compelling opportunity in the healthcare sector, particularly within the burgeoning Health Information Services industry. With a market capitalization of approximately $768.89 million, this..
SI-BONE, Inc. (NASDAQ: SIBN) is generating significant interest among investors in the healthcare sector, particularly in the medical devices industry. Headquartered in Santa Clara, California, SI-BONE specializes in solving complex..
Sionna Therapeutics, Inc. (NASDAQ: SION), a clinical-stage biopharmaceutical company, is drawing attention in the investment community with its promising pipeline targeting cystic fibrosis (CF). With a market capitalization of $922.96..
Relay Therapeutics, Inc. (NASDAQ: RLAY) is capturing the attention of investors with its significant potential upside, pegged at an impressive 292.33%. Operating within the healthcare sector and specializing in biotechnology,..
Immunome, Inc. (NASDAQ: IMNM) is capturing the attention of investors with its promising potential upside of 143.96%, as highlighted by recent analyst ratings. This clinical-stage biotechnology company, headquartered in Bothell,..
